1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N3387
    Licoricidin

    甘草西定

    Inhibitor 98.00%
    Licoricidin (LCD) 从甘草 Glycyrrhiza uralensis Fisch 中分离,具有抗癌活性。Licoricidin (LCD) 通过诱导周期停滞,诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),可用于结直肠癌的研究。Licoricidin (LCD) 通过抑制肿瘤血管生成和淋巴管生成以及肿瘤组织局部微环境的变化抑制肺转移。Licoricidin (LCD) 通过体外和体内 AktNF-κB 途径的失活,增强吉西他滨诱导的骨肉瘤 (OS) 细胞的细胞毒性。Licoricidin (LCD) 通过 ROS 清除阻断 UVA 诱导的光老化,限制 MMP-1 的活性,被认为是新的局部应用的抗衰老制剂中的活性成分。
    Licoricidin
  • HY-N1513
    Ganoderic acid H

    灵芝酸H

    Inhibitor 99.68%
    Ganoderic acid H 是一种从灵芝中提取的羊毛脂烷型三萜,能通过抑制转录因子AP-1 和 NF-kappaB 信号来抑制乳腺癌细胞细胞的生长和入侵。
    Ganoderic acid H
  • HY-N0176R
    Dihydroartemisinin (Standard)

    双氢青蒿素 (Standard)

    Inhibitor
    Dihydroartemisinin (Standard)是 Dihydroartemisinin 的分析标准品。本产品用于研究及分析应用。Dihydroartemisinin是一种有效的抗疟疾 (anti-malaria) 活性分子。
    Dihydroartemisinin (Standard)
  • HY-122830
    DD-03-171 Inhibitor 98.72%
    DD-03-171 是一种 PROTAC BTK 降解剂。DD-03-171 可通过降解 BTK、IKFZ1 和 IKFZ3 抑制套细胞淋巴瘤 (MCL) 细胞增殖 (IC50 = 5.1 nM),并延长淋巴瘤 PDX 模型小鼠的生存期。DD-03-171 还能抑制血小板功能和血栓形成。(粉色:BTK ligand 9 (HY-168292);黑色:连接体 (HY-28875);蓝色:Thalidomide-NH-CH2-COOH (HY-131717))。
    DD-03-171
  • HY-119931
    2-Hydroxychalcone Inhibitor 98.08%
    2-hydroxychalcone 是一种天然黄酮,是一种抗氧化剂,抑制脂质过氧化。2-hydroxychalcone 通过下调 Bcl-2 诱导凋亡。2-Hydroxychalcone 可抑制NF-kB 的激活。
    2-Hydroxychalcone
  • HY-N3536
    Canthin-6-one Inhibitor 99.92%
    Canthin-6-one 是一种吲哚生物碱,具有抗菌和抗炎活性。
    Canthin-6-one
  • HY-N0197R
    Baicalin (Standard)

    黄芩苷 (Standard)

    Inhibitor
    Baicalin (Standard) 是 Baicalin 的分析标准品。本产品用于研究及分析应用。Baicalin 作为一种类黄酮糖苷,是一种变构肉碱棕榈酰转移酶1 (CPT1)是激活剂。Baicalin 降低 NF-κB 表达。
    Baicalin (Standard)
  • HY-32735S
    Triptolide-d3

    雷公藤甲素 d3

    Inhibitor
    Triptolide-d3 是 Triptolide 的氘代物。Triptolide是从雷公藤根中提取的二萜类三环氧化物,具有免疫抑制,抗炎,抗增殖和抗肿瘤作用。 雷公藤内酯是 NF-κB 活化的抑制剂。
    Triptolide-d<sub>3</sub>
  • HY-14942A
    Berubicin hydrochloride Agonist
    Berubicin (RTA 744) hydrochloride 是一种可穿过血脑屏障的 Doxorubicin (HY-15142A) 的类似物。Berubicin hydrochloride 可抑制 P-gp 和 MRP1 介导的外排,并抑制多形性胶质母细胞瘤 (GBM) 生长。Berubicin hydrochloride 通过激活核因子 κB (NF-κB) 对白血病细胞产生细胞毒性作用,并诱导了神经母细胞瘤细胞凋亡 (apoptosis)。Berubicin hydrochloride 可用于神经系统相关的肿瘤研究。
    Berubicin hydrochloride
  • HY-N3181
    Nodosin Inhibitor 98.44%
    Nodosin 是一种可以从 Isodon serra 中分离得到的具有口服活性的二萜类化合物。Nodosin 可抑制肿瘤细胞增殖,诱导细胞周期阻滞和凋亡 (apoptosis)。Nodosin 也能抑制氧化应激、炎症反应和铁死亡 (ferroptosis)。 Nodosin 具有抗炎和抗肿瘤的活性。
    Nodosin
  • HY-15530
    CID-2858522 Inhibitor 99.78%
    CID-2858522 是一种高效的选择性抗原受体介导的 NF-κB 抑制剂,IC50 为 70 nM。
    CID-2858522
  • HY-Y1322
    Triphenyl phosphate

    磷酸三苯基酯

    Activator 99.67%
    Triphenyl phosphate 是一种有机磷酸盐阻燃剂。Triphenyl phosphate 可通过激活 MAOA/ROS/NFκB 破坏胎盘色氨酸代谢,诱发异常的神经行为。Triphenyl phosphate 促进核因子 κ B (NFκB)、白细胞介素-6肿瘤坏死因子α 等炎症因子诱导氧化应激。Triphenyl phosphate 可引起过敏性接触性皮炎。
    Triphenyl phosphate
  • HY-117987
    CPS-11 Inhibitor 99.39%
    CPS-11 (N-(Hydroxymethyl)thalidomide) 是 Thalidomide (HY-14658) 类似物,是一种有效的抗癌剂 (anti-cancer agent)。CPS-11 可抑制 NF-κB,激活 NFAT,通过升高 ROS 抑制细胞因子表达。CPS-11 对 MM (多发性骨髓瘤)细胞系表现出更广泛的活性谱和更高的效力。
    CPS-11
  • HY-N11004
    Erinacine C Inhibitor 98.61%
    Erinacine C 是 NF-κB 信号通路的抑制剂和 Nrf2 信号通路的激活剂。Erinacine C 具有抗氧化、神经保护和抗炎作用。
    Erinacine C
  • HY-N0510A
    Aristolochic acid A sodium

    马兜铃酸I钠盐

    Inhibitor 99.93%
    Aristolochic acid A (Aristolochic acid I; TR 1736) sodium 是植物提取物 Aristolochic acids 的主要成分,其存在于 AristolochiaAsarum 草本植物中。Aristolochic acid A sodium 显着降低激活蛋白1 (AP-1) 和 NF-κB 活性。Aristolochic acid A sodium 降低人细胞中膀胱癌相关 BLCAP 基因表达。
    Aristolochic acid A sodium
  • HY-W015883R
    Fumaric acid (Standard)

    反丁烯二酸 (Standard)

    Inhibitor
    Fumaric acid (Standard) 是 Fumaric acid 的分析标准品。本产品用于研究及分析应用。Fumaric acid 是一种不饱和二碳酸,是柠檬酸循环的中间产物,以 ATP 的形式提供细胞内能量。Fumaric acid 通过抑制 p38 MAPK 依赖的 NF-κB 信号通路发挥抗炎作用。Fumaric acid 可用于妊娠高血压的研究。
    Fumaric acid (Standard)
  • HY-B0289
    Erdosteine

    厄多司坦

    Inhibitor 99.54%
    Erdosteine 抑制脂多糖 (LPS) 诱导的 NF-κB 激活。Erdosteine 具有粘液调节,抗菌,抗炎和抗氧化作用。
    Erdosteine
  • HY-N2041R
    Myristic acid (Standard)

    肉豆蔻酸 (Standard)

    Activator
    Myristic acid (Standard) 是 Myristic acid 的分析标准品。本产品用于研究及分析应用。Myristic acid 是一种具有口服活性的饱和的 14 碳脂肪酸,存在于大多数动植物脂肪中,特别是乳脂和椰子油,棕榈油和肉豆蔻油。Myristic acid 通过 NF-κB 通路发挥抗炎活性。Myristic acid 具有抗菌、抗炎和镇痛作用。
    Myristic acid (Standard)
  • HY-B1449R
    Uridine (Standard)

    尿苷 (Standard)

    Inhibitor
    Uridine (Standard) 是 Uridine 的分析标准品。本产品用于研究及分析应用。Uridine (β-Uridine) 是一种核苷化合物,由尿嘧啶与核糖环组成,两者由β-N1-配糖键相连。
    Uridine (Standard)
  • HY-W011474R
    Geranylgeraniol (Standard)

    香叶基香叶醇 (Standard); 基牻牛儿醇 (Standard)

    Inhibitor
    Geranylgeraniol (Standard)是 Geranylgeraniol 的分析标准品。本产品用于研究及分析应用。Geranylgeraniol 是一种口服有效的维生素 K2 亚型,是甲戊酸途径 (mevalonate pathway) 的中间体。Geranylgeraniol 靶向 NF-kB 信号通路,可在动物模型中减轻脂多糖 (LPS) 诱导的小胶质细胞炎症。
    Geranylgeraniol (Standard)
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.